跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Odipin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Odipin
Approved
STANDARD
Odipin
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
28af088293b4a345
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
28af088293b4a345
Drug Approval Philippines Name
Odipin
Product Name
Odipin
Registration Number
DR-XY45317
Brand Name
Odipin
Generic Name
Nifedipine
Dosage Form
Extended-Release Tablet
Dosage Strength
30mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Primera Pharma, Corp.
Issuance Date
28 February 2022
Expiry Date
23 May 2027
Pharmacologic Category
Calcium-Channel Blocker
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
28af088293b4a345
Type
Standard
Back to Philippines FDA Approvals